Expertise in
1
conditions

Claudia S. Vieira

Porto, PT 
Expertise in
1
conditions
Porto, PT 

Overview

Claudia Vieira practices practicing medicine in Porto, Portugal.

Ms. Vieira is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Olfactory Neuroblastoma, Salivary Gland Tumors, Head and Neck Squamous Cell Carcinoma (HNSCC), and Breast Cancer.

She is actively involved in clinical research, co-authoring 31 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Porto, 4200072, Portugal
Other Locations
Vila Real, Portugal
Coimbra, Portugal
Lisbon, Portugal
Aveiro, 3810193, Portugal

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Multicenter, Open-Label, Non-Comparative, Three-Arm, Phase IIa Trial of Ipatasertib (GDC-0068) in Combination With Non-Taxane Chemotherapy Agents for Taxane-Pretreated Unresectable Locally Advanced or Metastatic TNBC Patients
A Multicenter, Open-Label, Non-Comparative, Three-Arm, Phase IIa Trial of Ipatasertib (GDC-0068) in Combination With Non-Taxane Chemotherapy Agents for Taxane-Pretreated Unresectable Locally Advanced or Metastatic TNBC Patients
Enrollment Status: Completed
Publish Date: July 26, 2024
Intervention Type: Drug
Study Drugs: Ipatasertib, Capecitabine, Eribulin, Carboplatin, Gemcitabine
Study Phase: Phase 2
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
A Randomized, Double-blind, Adaptive, Phase II/III Study of GSK3359609 or Placebo in Combination With Pembrolizumab for First-Line Treatment of PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Enrollment Status: Terminated
Publish Date: July 10, 2024
Intervention Type: Drug
Study Drugs: Feladilimab, Pembrolizumab
Study Phase: Phase 3
View 1 Less Clinical Trial

31 Total Publications

Longitudinal Changes in Somatosensory Function and Their Association with Pain Trajectory Groups in a Portuguese Cancer Center Cohort.
Longitudinal Changes in Somatosensory Function and Their Association with Pain Trajectory Groups in a Portuguese Cancer Center Cohort.
Journal: Biomedicines
Published: July 20, 2026

Frequently Asked Questions about Claudia S. Vieira

Is Claudia S. Vieira a top-rated expert for Olfactory Neuroblastoma?

MediFind is an objective health platform that identifies experts based on real-world data. Claudia S. Vieira is classified as an Advanced expert for Olfactory Neuroblastoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Claudia S. Vieira participate in research or clinical trials?

Yes. Claudia S. Vieira has published 31 articles and abstracts on conditions like Olfactory Neuroblastoma. You can view a list of Claudia S. Vieira's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Vieira's expertise for a condition
ConditionClose
      View All 9 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile